These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26395266)

  • 1. Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells.
    Bertucci A; Prasetyanto EA; Septiadi D; Manicardi A; Brognara E; Gambari R; Corradini R; De Cola L
    Small; 2015 Nov; 11(42):5687-95. PubMed ID: 26395266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222.
    Brognara E; Fabbri E; Montagner G; Gasparello J; Manicardi A; Corradini R; Bianchi N; Finotti A; Breveglieri G; Borgatti M; Lampronti I; Milani R; Dechecchi MC; Cabrini G; Gambari R
    Int J Oncol; 2016 Mar; 48(3):1029-38. PubMed ID: 26708164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of 3-methyladenine therapy and Asn-Gly-Arg (NGR)-modified mesoporous silica nanoparticles loaded with temozolomide for glioma therapy in vitro.
    Zhang P; Tang M; Huang Q; Zhao G; Huang N; Zhang X; Tan Y; Cheng Y
    Biochem Biophys Res Commun; 2019 Feb; 509(2):549-556. PubMed ID: 30600180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting miR‑155‑5p and miR‑221‑3p by peptide nucleic acids induces caspase‑3 activation and apoptosis in temozolomide‑resistant T98G glioma cells.
    Milani R; Brognara E; Fabbri E; Manicardi A; Corradini R; Finotti A; Gasparello J; Borgatti M; Cosenza LC; Lampronti I; Dechecchi MC; Cabrini G; Gambari R
    Int J Oncol; 2019 Jul; 55(1):59-68. PubMed ID: 31180529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells.
    Liang P; Shi H; Zhu W; Gui Q; Xu Y; Meng J; Guo X; Gong Z; Chen H
    Oncotarget; 2017 Jan; 8(5):7533-7539. PubMed ID: 27893419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakable mesoporous silica nanoparticles for targeted drug delivery.
    Maggini L; Cabrera I; Ruiz-Carretero A; Prasetyanto EA; Robinet E; De Cola L
    Nanoscale; 2016 Apr; 8(13):7240-7. PubMed ID: 26974603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
    Han J; Chen Q
    Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.
    Gong A; Ge N; Yao W; Lu L; Liang H
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):531-8. PubMed ID: 25047724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
    Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z
    Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
    Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas.
    Czabanka M; Bruenner J; Parmaksiz G; Broggini T; Topalovic M; Bayerl SH; Auf G; Kremenetskaia I; Nieminen M; Jabouille A; Mueller S; Harms U; Harms C; Koch A; Heppner FL; Vajkoczy P
    Eur J Cancer; 2013 Jun; 49(9):2243-52. PubMed ID: 23499430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
    Saito R; Bringas JR; Panner A; Tamas M; Pieper RO; Berger MS; Bankiewicz KS
    Cancer Res; 2004 Oct; 64(19):6858-62. PubMed ID: 15466173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
    Peng Y; Huang J; Xiao H; Wu T; Shuai X
    Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
    Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q
    Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    Ling Y; Wei K; Zou F; Zhong S
    Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant treatment with temozolomide enhances apoptotic cell death in glioma cells induced by photodynamic therapy with talaporfin sodium.
    Miki Y; Akimoto J; Omata H; Moritake K; Hiranuma M; Hironaka C; Fujiwara Y; Beppu M
    Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):556-64. PubMed ID: 25262961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
    Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.
    Hu J; Wang J; Wang G; Yao Z; Dang X
    Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy.
    Qian X; Ren Y; Shi Z; Long L; Pu P; Sheng J; Yuan X; Kang C
    Mol Pharm; 2012 Sep; 9(9):2636-45. PubMed ID: 22853427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.